ClinicalTrials.gg
Not yet recruitingNCT06814639Updated Feb 7, 2025

The Aims of the Study Are to Translate the Index of Professional Governance (IPG 3.0) Into Italian and Validate It and to Assess the State of Professional Governance in an Italian Hospital (ISMETT)

An observational study in Validation Study, sponsored by The Mediterranean Institute for Transplantation and Advanced Specialized Therapies. Not yet recruiting. Per ClinicalTrials.gov, last updated 2025-02-07.

Sponsored by The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
75
Sex
All
01

Study summary

Professional Governance (PG) is a way to actualize better work environments and structural empowerment. PG has a history over many years in the healthcare industry and has been defined as multidimensional organizational characteristics that encompass the structure and processes through which professionals direct, control and regulate one another's goal-oriented efforts. Multiple studies over the years have shown that PG can lead to empowered personnel and quality of care delivered.

In many organizations, governance is primarily controlled by management. The responsibility for managing professional practice should, however, be shared by staff and leaders, and in order to empower staff, they should be engaged in identifying areas for improvement. In addition, evidence-based practice should be enabled by allocating sufficient time, research and access to evidence sources.

The participation element refers to who creates and participates in governance activities on different levels. Successful professional governance structures have been linked to a positive professional practice environment. An effective structure with true sharing of decision-making between management and personnel will also contribute to optimal patient outcomes.

To evaluate whether an organization's governance is empowering and professional, it must be measured. Thus, various instruments to measure nurses' participation in professional governance have been presented. The Index of Professional Nursing Governance (IPNG) has been used in more than 250 international healthcare organizations during the last 20 years to evaluate implementation of their management models.

Hess created the IPNG for measuring professional governance along a conceptual continuum from traditional, through shared to self-governance models. Hess has since continued to advance the questionnaire. At the same time, an extended tool was created with all professional figures involved, the so called "Index of Professional Governance" (IPG). Several revisions have been made over time up to the current version of the IPG 3.0 The IPG measures the governance of hospital-based professional, based on a model of governance derived from the literature, in 5 dimensions: personnel, information, resources, participation and practice. Those five dimensions are covered by 50 items. Respondents use a 5-point scale to identify the group that dominates certain areas of governance stated in the items, ranging from 'management/administration only' (1p), through 'equally shared by staff and management/administration' (3p) to 'staff only' (5p). The points for each dimension, and overall governance, are then organized together, analyzed and used to place the organization's governance on the continuum from traditional to self-governance.

Previously translated from its original language, English-American into Arabic, British, Finnish, French, German, Korean, Portuguese, it is structured in five dimensions: staff, information, resources, participation and practice. These 5 dimensions are analyzed in 50 items.

Aims of the study:

  1. To translate the Index of Professional Governance (IPG 3.0) into Italian and validate it;
  2. To assess the state of professional governance in an Italian hospital (ISMETT).
02

Conditions studied

  • Validation Study

Keywords

  • IPG tool
  • professional governance
  • translation
  • validation
03

In context

Lead sponsor

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies is the lead sponsor of 13 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Employees of 5 Italian hospital structures and representative of different professions (the administrative area, the nursing area, the area of the other health professions and the medical area).

Eligibility criteria

Inclusion Criteria:

  • 1 year of professional seniority
  • possess adequate linguistic skills certified by passing an English test (prepared by the linguistic services of the promoting center).
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
75 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Inter-rater agreement percentage in evaluating the conceptual equivalence of the italian translation of the IPG.

    Time frame: Feb-Mar 2025: Recruitment of evaluators and assessment of language proficiency. Apr-Sep 2025: Evaluation of the proposed and collection of evaluators' judgements and final approval of the translated items. Oct 2025: Final data analysis and study closure.

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06814639
Lead sponsor
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Responsible party
Sponsor
First posted
Feb 7, 2025
Start date
Feb 6, 2025 (estimated)
Primary completion
Oct 31, 2025 (estimated)
Completion
Oct 31, 2025 (estimated)
Last update
Feb 7, 2025

Study contacts

Giuseppe Enea, Physiotherapy
Contact
genea@ismett.edu
+39 0912192410
Elena Conoscenti, Nurse
Contact
econoscenti@ismett.edu
+39 0912192410

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion